Published in Cancer Epidemiol Biomarkers Prev on November 01, 1997
A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A (2001) 2.12
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res (2008) 1.95
Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer (1999) 1.26
Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 0.86
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes. Am J Cancer Res (2013) 0.80
Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model. BMC Cancer (2015) 0.75
NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer. Oncotarget (2017) 0.75
Helicobacter pylori infection and gastric lymphoma. N Engl J Med (1994) 10.26
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77
Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet (1993) 3.60
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. J Reprod Med (2001) 3.29
Endogenous hormones and breast cancer risk. Epidemiol Rev (1993) 3.27
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst (2001) 3.05
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03
Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst (1994) 2.93
Aspirin use and chronic diseases: a cohort study of the elderly. BMJ (1989) 2.89
Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med (1995) 2.83
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (1997) 2.74
Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst (2001) 2.43
Toward the primary prevention of cancer. Science (1991) 2.41
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer (1992) 2.40
Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 2.36
Meat consumption and the risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies. Diabetologia (2009) 2.35
Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA (1992) 2.29
Decreased mortality in users of estrogen replacement therapy. Arch Intern Med (1991) 2.26
Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med (1989) 2.25
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ (1997) 2.05
Changes in amino acids, ammonium, and coagulation factors after transcervical resection of the endometrium with a glycine solution used for uterine irrigation. Am J Obstet Gynecol (1995) 2.04
Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol (2001) 2.02
Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer (1988) 2.02
Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet (2000) 1.98
Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology (1991) 1.96
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia. Clin Chim Acta (1981) 1.91
Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer (1987) 1.91
Aromatase and breast cancer susceptibility. Endocr Relat Cancer (1999) 1.89
Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst (1994) 1.87
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85
The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res (1995) 1.84
Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80
Further observations on prognostic factors in cancer of the female breast. Cancer (1969) 1.79
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet (1981) 1.77
A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med (1990) 1.76
Global consensus statement on menopausal hormone therapy. Climacteric (2013) 1.74
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev (2000) 1.69
Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst (2001) 1.69
Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice. Ann Rheum Dis (1980) 1.68
Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res (1988) 1.68
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol (1982) 1.66
Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev (1997) 1.64
Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol (1990) 1.64
Menopausal hot flushes and night sweats: where are we now? Climacteric (2011) 1.61
Diagnosis and management of a tuberculous, tuboappendiceal fistula. Am J Obstet Gynecol (1988) 1.60
Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst (1985) 1.60
Cancer of the gastrointestinal tract among Japanese and white immigrants in Los Angeles County. J Natl Cancer Inst (1987) 1.59
Comparison of early and late respondents to a postal health survey questionnaire. Epidemiology (1993) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst (1986) 1.54
From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res (1991) 1.53
Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in White, African-American, and Asian-American men in Los Angeles County. Cancer Epidemiol Biomarkers Prev (1999) 1.51
Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst (1987) 1.51
Prevalence of chronic disease and health practices in a retirement community. J Chronic Dis (1986) 1.51
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril (1994) 1.51
Do regular ovulatory cycles increase breast cancer risk? Cancer (1985) 1.50
Why delay the obvious need for milder forms of ovarian stimulation? Hum Reprod (1997) 1.50
The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer (1993) 1.50
Pyroglutamic aciduria--a new inborn error of metabolism. Scand J Clin Lab Invest (1970) 1.49
Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol (1988) 1.48
Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer (2000) 1.47
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer (2000) 1.46
A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res (1997) 1.46
Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer (1997) 1.45
Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol (1999) 1.45
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril (1995) 1.42
Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab (1999) 1.42
Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol (1987) 1.42
Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet (2000) 1.41
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41